These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9236953)

  • 1. The severe impairment battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.
    Schmitt FA; Ashford W; Ernesto C; Saxton J; Schneider LS; Clark CM; Ferris SH; Mackell JA; Schafer K; Thal LJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S51-6. PubMed ID: 9236953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.
    Mohs RC; Knopman D; Petersen RC; Ferris SH; Ernesto C; Grundman M; Sano M; Bieliauskas L; Geldmacher D; Clark C; Thal LJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S13-21. PubMed ID: 9236948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring cognition in advanced Alzheimer's disease for clinical trials.
    Schmitt FA; Cragar D; Ashford JW; Reisberg B; Ferris S; Möbius HJ; Stöffler A
    J Neural Transm Suppl; 2002; (62):135-48. PubMed ID: 12456059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study.
    Mackell JA; Ferris SH; Mohs R; Schneider L; Galasko D; Whitehouse P; Schmitt F; Sano M; Thal LJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S65-9. PubMed ID: 9236955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration.
    Stern RG; Mohs RC; Davidson M; Schmeidler J; Silverman J; Kramer-Ginsberg E; Searcey T; Bierer L; Davis KL
    Am J Psychiatry; 1994 Mar; 151(3):390-6. PubMed ID: 8109647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global measures: utility in defining and measuring treatment response in dementia.
    Reisberg B
    Int Psychogeriatr; 2007 Jun; 19(3):421-56. PubMed ID: 17480241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.
    Feldman H; Gauthier S; Hecker J; Vellas B; Xu Y; Ieni JR; Schwam EM;
    Int J Geriatr Psychiatry; 2005 Jun; 20(6):559-69. PubMed ID: 15920715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open-label, single-arm, multicenter clinical study.
    Holthoff V; Ferris S; Gauthier S; Ihl R; Robert P; Winblad B; Sternberg K; Tennigkeit F;
    Int J Geriatr Psychiatry; 2013 Feb; 28(2):164-72. PubMed ID: 22492589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.
    Hallikainen I; Hänninen T; Fraunberg M; Hongisto K; Välimäki T; Hiltunen A; Karppi P; Sivenius J; Soininen H; Koivisto AM;
    Int Psychogeriatr; 2013 Aug; 25(8):1335-44. PubMed ID: 23676340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive and functional decline and their relationship in patients with mild Alzheimer's dementia.
    Liu-Seifert H; Siemers E; Sundell K; Price K; Han B; Selzler K; Aisen P; Cummings J; Raskin J; Mohs R
    J Alzheimers Dis; 2015; 43(3):949-55. PubMed ID: 25125457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study.
    Ferris SH; Mackell JA; Mohs R; Schneider LS; Galasko D; Whitehouse PJ; Schmitt FA; Sano M; Thomas RG; Ernesto C; Grundman M; Schafer K; Thal LJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S1-12. PubMed ID: 9236947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of the functional independence measure for assessment of patients with Alzheimer's disease and vascular dementia.
    Tanaka N; Nakatsuka M; Ishii H; Nakayama R; Hosaka R; Meguro K
    Psychogeriatrics; 2013 Dec; 13(4):199-205. PubMed ID: 24289460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease: the CERAD Behavior Rating Scale for Dementia. The Alzheimer's Disease Cooperative Study.
    Patterson MB; Mack JL; Mackell JA; Thomas R; Tariot P; Weiner M; Whitehouse PJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S40-4. PubMed ID: 9236951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
    Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease.
    Zubenko GS; Zubenko WN; McPherson S; Spoor E; Marin DB; Farlow MR; Smith GE; Geda YE; Cummings JL; Petersen RC; Sunderland T
    Am J Psychiatry; 2003 May; 160(5):857-66. PubMed ID: 12727688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease.
    Galasko D; Schmitt F; Thomas R; Jin S; Bennett D;
    J Int Neuropsychol Soc; 2005 Jul; 11(4):446-53. PubMed ID: 16209425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic validity of the Alzheimer's disease functional assessment and change scale in mild cognitive impairment and mild to moderate Alzheimer's disease.
    Manero RM; Casals-Coll M; Sánchez-Benavides G; Rodríguez-de los Reyes ON; Aguilar M; Badenes D; Molinuevo JL; Robles A; Barquero MS; Antúnez C; Martínez-Parra C; Frank-García A; Fernández M; Blesa R; Peña-Casanova J;
    Dement Geriatr Cogn Disord; 2014; 37(5-6):366-75. PubMed ID: 24556708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A neuropsychological test battery for use in Alzheimer disease clinical trials.
    Harrison J; Minassian SL; Jenkins L; Black RS; Koller M; Grundman M
    Arch Neurol; 2007 Sep; 64(9):1323-9. PubMed ID: 17846273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between Dementia Rating Scale performance and neurocognitive domains in Alzheimer's disease.
    Knox MR; Lacritz LH; Chandler MJ; Munro Cullum C
    Clin Neuropsychol; 2003 May; 17(2):216-9. PubMed ID: 13680428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.